ArticleTherapeutic advances in respiratory disease

Retraction: "Two-day versus seven-day course of levofloxacin in acute COPD exacerbation: a randomized controlled trial".

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.